Want to see IN:VALIANTLAB full AI Analyst Report?
Valiant Laboratories Ltd. (VALIANTLAB) Income Statement
Valiant Laboratories Ltd. Income Statement
Last quarter (Q1 2027), Valiant Laboratories Ltd.'s total revenue was $1.15B, an increase of 146.22% from the same quarter last year. In Q1, Valiant Laboratories Ltd.'s net income was $211.03M. See Valiant Laboratories Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 2.37B | $ 1.39B | $ 1.82B | $ 3.34B | $ 2.92B | |
| $ 272.66M | $ 222.17M | $ 115.76M | $ 390.07M | $ 523.21M | |
| $ 269.16M | $ 43.88M | $ 43.13M | $ 156.20M | $ 123.16M | |
| Depreciation and Amortization | $ 60.40M | $ 20.93M | $ 19.66M | $ 15.63M | $ 24.90M |
| $ 87.11M | $ 7.55M | $ -84.08M | $ 399.53M | $ 442.67M | |
| $ 3.50M | $ 178.29M | $ 72.63M | $ 341.57M | $ 400.05M | |
| $ 4.18M | $ -193.41M | $ 0.00 | $ 39.80M | $ 16.99M | |
| $ 7.68M | $ -15.13M | $ -7.70M | $ 381.36M | $ 417.04M | |
| $ -32.68M | $ -22.01M | $ 3.20M | $ 289.98M | $ 274.96M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.51 | $ -0.51 | $ 0.08 | $ 6.67 | $ 6.33 |
| Diluted EPS | $ -0.51 | $ -0.51 | $ 0.08 | $ 6.67 | $ 6.33 |
| Weighted Average Shares Outstanding | 64.08M | 43.16M | 38.01M | 43.45M | 43.45M |
| Weighted Average Shares Outstanding (Diluted) | 64.08M | 43.16M | 38.01M | 43.45M | 43.45M |
Currency in INR